Chroma Technologies Inc.

Strategies for Building Early-Stage Pharmaceutical Pipelines Through External Sources.
M2 Presswire; 11/20/2009; 999 words; ...Decision Resources, Inc.'s new report...stage products and technologies? - What are the...novel targets, technology platforms...technologies, technologies for drug repositioning...diversification. - Technologies of interest...Novel Targets - Technology Platforms Select...Myers ...

Research and Markets: Strategies for Building Early-Stage Pharmaceutical Pipelines Through External Sources.
Business Wire; 11/20/2009; 917 words; ...Decision Resources, Inc.'s new report...stage products and technologies? * What are the...novel targets, technology platforms...technologies, technologies for drug repositioning...diversification. * Technologies of interest...Novel Targets * Technology Platforms Select...Myers ...

2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer.
PR Newswire; 11/16/2009; 2946 words; ...Airmedia Group Inc ; Akamai Technologies ; AkzoNobel (EURONEXT...ALLL1); Alpha Networks Inc. (TWSE: 3380); Aluminum...AVerMedia Technologies Inc. (TWSE: 2417); Ayala...OTCBB: AYAAF); Baidu Inc. ; Banca MPS (FTSE...Company (TWSE: 2891); Chroma Ate (TWSE: 2360...

On the move
Pharmaceutical Executive Europe (Online); 11/11/2009; 662 words; ...Ed Hodgkin, CEO of Biotica Technology Ltd; and Dr Sam Williams...president and CEO of Cellzome Inc.; Dr Jeremy Haigh, VP and...Ltd; Ian Nicholson, CEO of Chroma Therapeutics Ltd.; and Peter...PharmaNet Development Group, Inc. (US), a provider of clinical...

BIO-Europe 2009 Announces Program Highlights.
Pediatrics Week; 11/7/2009; 2488 words; ...efficiently initiating a partnering interest in technology and programs. Panelists include Gayle...Margaret Beer of Merck & Co., Inc. Clinical Trial Regulations 2009: Not...Arlene Morris of Affymax, Ian Nicholson of Chroma Therapeutics and Dan Zabrowski of F...